Press Releases
KIFFIK Biomedical has been recognized as Top Biomarker Access Technology 2026 by Life Sciences Review. The October 2026 feature highlights KIFFIK’s technology for non-invasive access to interstitial fluid and insights from Chief Scientific Officer Luigi (Gino) Martini, PhD....
Clinical device expected availability in 2026 Scalable platform launch planned for 2027 [ MIAMI ] — KIFFIK Biomedical Inc. (“KIFFIK”), a leader in interstitial fluid (ISF)-based diagnostics, today announced a strategic manufacturing partnership with Beacon MedTech Solutions to deliver its K-EXP™ platform. The K-EXP™ clinical device is expected to be...
Clinical device expected availability in 2026 Scalable platform launch planned for 2027 [ MIAMI ] — KIFFIK Biomedical Inc. (“KIFFIK”), a leader in interstitial fluid (ISF)-based diagnostics, today announced a strategic manufacturing partnership with Beacon MedTech Solutions to deliver its K-EXP™ platform. The K-EXP™ clinical device is expected to be...
Clinical device expected availability in 2026 Scalable platform launch planned for 2027 [ MIAMI ] — KIFFIK Biomedical Inc. (“KIFFIK”), a leader in interstitial fluid (ISF)-based diagnostics, today announced a strategic manufacturing partnership with Beacon MedTech Solutions to deliver its K-EXP™ platform. The K-EXP™ clinical device is expected to be...
Building the Foundation for the Next Generation of Biological Measurement